Novel inhibitors of the type 1 transporter for glycine (GlyT1) as antipsychotic agents

By Lowe III John A  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 11, 2005-11 ,pp. : 1657-1662

Informa Healthcare

Access to resources Recommend Favorite

Sarcosine-Based Glycine Transporter Type-1 (GlyT-1) Inhibitors Containing Pyridazine Moiety: A Further Search for Drugs with Potential to Influence Schizophrenia Negative Symptoms

By  

Current Pharmaceutical Design, Vol. 21, Iss. 17, 2015-05 ,pp. : 2291-2303

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress in the Discovery of Non-Sarcosine Based GlyT1 Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 2, 2010-02 ,pp. : 170-186

Bentham Science Publishers

Access to resources Recommend Favorite

Glycine Reuptake Inhibition as a New Therapeutic Approach in Schizophrenia: Focus on the Glycine Transporter 1 (GlyT1)

By  

Current Pharmaceutical Design, Vol. 19, Iss. 7, 2013-02 ,pp. : 1311-1320

Bentham Science Publishers

Access to resources Recommend Favorite

Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat

By Black Mark   Varty Geoffrey   Arad Michal   Barak Segev   Levie Amaya   Boulay Denis   Pichat Philippe   Griebel Guy   Weiner Ina  

Psychopharmacology, Vol. 202, Iss. 1-3, 2009-01 ,pp. : 385-396

Springer Publishing Company

Access to resources Recommend Favorite